Two Seas Capital LP - 30 Jun 2025 SCHEDULE 13G/A Report for Adaptimmune Therapeutics PLC Ordinary Shares, par value GBP 0.001 per share (ADAP)

Filing Manager: Two Seas Capital LP
Reporting Manager: Two Seas Capital LP
Security: Adaptimmune Therapeutics PLC Ordinary Shares, par value GBP 0.001 per share
Symbol: ADAP
Shares outstanding: 1,593,931,835 shares
Disclosed Ownership: 135,484,206 shares
Ownership: 8.5%
Form type: SCHEDULE 13G/A
Filing time: 13 Aug 2025, 17:43:42 UTC
Date of event: 30 Jun 2025
Previous filing: 15 May 2025
Next filing: 14 Nov 2025
SEC: View on sec.gov

Reporting Managers (3)

Name	Ownership	Shares Owned	sole voting power	Signature	Title
Two Seas Capital LP	8.5%	135,484,206	135,484,206	/s/ Sina Toussi	Sina Toussi / Managing Member of Two Seas Capital GP LLC, its General Partner
Two Seas Capital GP LLC	8.5%	135,484,206	135,484,206	/s/ Sina Toussi	Sina Toussi / Managing Member
Sina Toussi	8.5%	135,484,206	135,484,206	/s/ Sina Toussi	Sina Toussi / Self